Compare TRS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRS | CERT |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2007 | 2020 |
| Metric | TRS | CERT |
|---|---|---|
| Price | $35.71 | $9.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $41.50 | $13.25 |
| AVG Volume (30 Days) | 691.7K | ★ 2.4M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ 68.70 | N/A |
| EPS | ★ 1.08 | 0.07 |
| Revenue | ★ $1,013,740,000.00 | $415,551,000.00 |
| Revenue This Year | $11.57 | $10.82 |
| Revenue Next Year | N/A | $6.77 |
| P/E Ratio | ★ $32.52 | $134.09 |
| Revenue Growth | ★ 11.83 | 11.47 |
| 52 Week Low | $19.33 | $8.03 |
| 52 Week High | $40.34 | $15.69 |
| Indicator | TRS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 63.15 | 50.60 |
| Support Level | $33.65 | $8.42 |
| Resistance Level | $34.48 | $9.17 |
| Average True Range (ATR) | 0.85 | 0.37 |
| MACD | 0.27 | 0.10 |
| Stochastic Oscillator | 97.82 | 65.87 |
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.